Abstract
Over the past few years, nanotechnology has emerged as a promising tool in the field of biomedical sciences for the diagnosis, treatment, and management of zoonotic diseases related to the central nervous system. Complicated pathogenesis of zoonotic diseases, blood-brain barrier, and unavailability of specified channels for drug delivery have made alternate treatment regimens more cumbersome and delayed, leading to increased prevalence of these diseases in different human and animal population settings. These zoonotic diseases also pose serious risks to global health and cause huge economic losses in developing countries by causing epidemics and pandemics. Nanomaterials or modified nanoformulations provide suitable prophylactic, preventive (antiviral, antibacterial, and antiparasitic), and functional outcomes to resolve chronic and acute infections. This technology has also been considered as the best alternative to antibiotics, antivirals, and antiparasitic drugs that promote resistance against viral, bacterial, and parasitic infections. These nanotherapeutics also provide timely solutions by avoiding unexpected further health risks to humans, animals, and the surrounding environment, thus ensuring biosafety in healthcare settings. Target-selected nano-materials such as metal nanoparticles, polymeric nanoparticles, nanoemulsions, liposomes, and nanocrystals are administered through various routes in animals and humans, and these nanoparticles bind or manipulate the specific cellular receptors in host cells and also guide drug molecules along the drug delivery pathways in the central nervous system. In this chapter, various currently used diagnostics and treatment regimens of nanotechnology have been discussed among different neurodegenerative diseases such as cerebral malaria, trypanosomiasis, rabies, and listeriosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aditi, Shariff M (2019) Nipah virus infection: a review. Epidemiol Infect 147:e95. https://doi.org/10.1017/S0950268819000086
Ahmad W, Naeem MA, Akram Q et al (2021) Exploring rabies endemicity in Pakistan: major constraints & possible solutions. Acta Trop 221:106011
Alyautdin R, Khalin I, Nafeeza MI, Haron MH, Kuznetsov D (2014) Nanoscale drug delivery systems and the blood–brain barrier. Int J Nanomedicine 9:795–811
Ambrosi A, Airo F, Merkoçi A et al (2010) Enhanced gold nanoparticle-based ELISA for a breast cancer biomarker. J Anal Chem 82(3):1151–1156
Banerjee S, Gupta N, Kodan P et al (2019) Nipah virus disease: a rare and intractable disease. Intractable Rare Dis Res 8(1):1–8
Bansal A, Gamal W, Wu X et al (2019) Evaluation of an adjuvanted hydrogel-based pDNA nanoparticulate vaccine for rabies prevention and immunocontraception. Nanomedicine 21:102049
Barratt G (2003) Colloidal drug carriers: achievements and perspectives. Cell Mol Life Sci 60:21–37
Ben-Harari RR, Connolly MP et al (2019) High burden and low awareness of toxoplasmosis in the United States. J Postgrad Med 131(2):103–108
Bruno L, Nappo MA, Ferrari L et al (2022) Nipah virus disease: epidemiological, clinical, diagnostic and legislative aspects of this unpredictable emerging zoonosis. Animals 13(1):159
Chaudhary V (2022) Prospects of green nanotechnology for efficient management of neurodegenerative diseases. Front Nanotechnol 4:1055708. https://doi.org/10.3389/fnano.2022.1055708
Chaudhary V et al (2023) High-performance H2 sensor based on Polyaniline-WO3 nanocomposite for portable batteries and breathomics-diagnosis of irritable bowel syndrome. Int J Hydrog Energy. https://doi.org/10.1016/j.ijhydene.2023.08.151
Cheng L, Wang C, Feng L, Yang K, Liu Z (2014) Functional nanomaterials for phototherapies of cancer. Chem Rev 114(21):10869–10939. https://doi.org/10.1021/cr400532z
Chhabra R, Tosi G, Grabrucker AM (2015) Emerging use of nanotechnology in the treatment of neurological disorders. Curr Pharm Des 21(22):3111–3130
Cui D, Tian F, Coyer SR, Wang J, Pan B, Gao F, Chen J (2020) Recent advances in the development of functional nanosystems for cancer imaging and therapy. Adv Healthc Mater 9(23):2001417. https://doi.org/10.1002/adhm.202001417
Date AA, Joshi MD, Patravale VB (2007) Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles. Adv Drug Deliv Rev 59(6):505–521
Davis ME, Chen ZG, Shin DM (2008) Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 7(9):771–782. https://doi.org/10.1038/nrd2614
Díaz-Caballero M, Fernández MR, Navarro S, Ventura S (2018) Prion-based nanomaterials and their emerging applications. Prion 12(5–6):266–272
Dreaden EC, Austin LA, Mackey MA, El-Sayed MA (2012) Size matters: gold nanoparticles in targeted cancer drug delivery. Ther Deliv 3(4):457–478. https://doi.org/10.4155/tde.12.9
Eiden M, Gedvilaite A, Leidel F, Ulrich RG, Groschup MH (2021) Vaccination with prion peptide-displaying polyomavirus-like particles prolongs incubation time in scrapie-infected mice. Virus 13(5):811
Falardeau J, Trmčić A, Wang S et al (2021) The occurrence, growth, and biocontrol of Listeria monocytogenes in fresh and surface-ripened soft and semisoft cheeses. Compr Rev Food Sci Food Saf 20(4):4019–4048
Farokhzad OC, Langer R (2009) Impact of nanotechnology on drug delivery. ACS Nano 3(1):16–20. https://doi.org/10.1021/nn900002m
Gautam A (2022) Towards modern-age advanced sensors for the management of neurodegenerative disorders: current status, challenges and prospects. ECS Sensor Plus 1:042401
Gilch S, Schätzl HM (2009) Aptamers against prion proteins and prions. CMLS 66:2445–2455
Glor SB, Edelhofer R, Grimm F, Deplazes P, Basso W et al (2013) Evaluation of a commercial ELISA kit for detection of antibodies against Toxoplasma gondii in serum, plasma and meat juice from experimentally and naturally infected sheep. Parasit Vectors 6:85
Goh GX, Tan K, Ang SP, Wang F, Tchoyoson Lim CC (2020) Neuroimaging in zoonotic outbreaks affecting the central nervous system: are we fighting the last war? AJNR Am J Neuroradiol 41(10):1760–1767. https://doi.org/10.3174/ajnr.A6727
Grace D, Mutua FK, Ochungo P, Kruska RL, Jones K, Brierley L, Lapar ML, Said MY, Herrero MT, Phuc PM, Thao NB (2012) Mapping of poverty and likely zoonoses hotspots. International Livestock Research Institute
Grace E, Asbill S, Virga K (2015) Naegleria fowleri: pathogenesis, diagnosis, and treatment options. Antimicrob Agents Chemother 59(11):6677–6681
Gref R, Domb A, Quellec P, Blunk T, Müller RH, Verbavatz JM, Langer R (1995) The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev 16:215–233
Hilderbrand SA, Weissleder R (2010) Near-infrared fluorescence: application to in vivo molecular imaging. Curr Opin Chem Biol 14(1):71–79. https://doi.org/10.1016/j.cbpa.2009.12.008
Idro R, Marsh K, John CC, Newton CR (2010) Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res 68(4):267–274
Ironside JW, Ritchie DL, Head MW (2018) Prion diseases. Handb Clin Neurol 145:393–403
Jokerst JV, Lobovkina T, Zare RN, Gambhir SS (2011) Nanoparticle PEGylation for imaging and therapy. Nanomedicine 6(4):715–728. https://doi.org/10.2217/nnm.11.19
Kasalica A, Vuković V, Vranješ A, Memiši N et al (2011) Listeria monocytogenes in milk and dairy products. Biotechnol Anim Husb 27(3):1067–1082
Kayser O, Kiderlen AF (2003) Delivery strategies for antiparasitics. Expert Opin Investig Drugs 12:197–207
Keller G, Binyamin O, Frid K, Saada A, Gabizon R (2019) Mitochondrial dysfunction in preclinical genetic prion disease: a target for preventive treatment? Neurobiol Dis 124:57–66
Kerry RG, Malik S, Redda YT (2019) Nano-based approach to combat emerging viral (NIPAH virus) infection. Nanomedicine 18:196–220
Kouassi GK, Wang P, Sreevatan S, Irudayaraj J (2007) Aptamer-mediated magnetic and gold-coated magnetic nanoparticles as detection assay for prion protein assessment. Biotechnol Prog 23(5):1239–1244
Kumar J, Eraña H, López-Martínez E, Claes N, Martín VF, Solís DM, Bals S, Cortajarena AL, Castilla J, Liz-Marzán LM (2018) Detection of amyloid fibrils in Parkinson’s disease using plasmonic chirality. Proc Natl Acad Sci U S A 115(13):3225–3230
Kumari A, Yadav SK, Yadav SC (2010) Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 75(1):1–18
Lasic DD, Martin FJ, Mayhew E (1995) Stealth liposomes. Ann Biomed Eng 19:59s
Lee KK, Karr SL Jr, Wong MM, Hoeprich PD (1979) In vitro susceptibilities of Naegleria fowleri strain HB-1 to selected antimicrobial agents, singly and in combination. Antimicrob Agents Chemother 16(2):217–220
Lee J, Kim SY, Hwang KJ, Ju YR, Woo HJ (2013) Prion diseases as transmissible zoonotic diseases. Osong Public Health Res Perspect 4(1):57–66
Luhr KM, Löw P, Taraboulos A, Bergman T, Kristensson K (2009) Prion adsorption to stainless steel is promoted by nickel and molybdenum. J Gen Virol 90(11):2821–2828
McLauchlin J, Rees CE, Dodd CE (2013) Listeria monocytogenes and the genus Listeria. In: The prokaryotes: Firmicutes and Tenericutes. Springer, Berlin, pp 241–259
Miller MB, Supattapone S (2011) Superparamagnetic nanoparticle capture of prions for amplification. J Virol 85(6):2813–2817
Moon JJ, Suh H, Li AV, Ockenhouse CF, Yadava A, Irvine DJ (2012) Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction. Proc Natl Acad Sci U S A 109(4):1080–1085. https://doi.org/10.1073/pnas.1112648109
Mosqueira VC, Loiseau PM, Bories C, Legrand P, Devissaguet JP, Barratt G (2004) Efficacy and pharmacokinetics of intravenous nanocapsule formulations of halofantrine in Plasmodium berghei-infected mice. Antimicrob Agents Chemother 48(4):1222–1228
Mukherjee S, Ray S, Thakur RS (eds) (2019) Nanotherapeutics: from laboratory to clinic. CRC Press
Mura S, Nicolas J, Couvreur P (2013) Stimuli-responsive nanocarriers for drug delivery. Nat Mater 12(11):991–1003. https://doi.org/10.1038/nmat3776
Muro S (2012) Challenges in design and characterization of ligand-targeted drug delivery systems. J Control Release 164(2):125–137
Murugesan S, Scheibel T (2020) Copolymer/clay nanocomposites for biomedical applications. Adv Funct Mater 30(17):1908101
Nightingale KK, Schukken YH, Nightingale CR, Fortes ED, Ho AJ, Her Z, Grohn YT, McDonough PL, Wiedmann M et al (2004) Ecology and transmission of Listeria monocytogenes infecting ruminants and in the farm environment. Appl Environ Microbiol 70(8):4458–4467
Prayag K, Surve DH, Paul AT, Kumar S, Jindal AB (2020) Nanotechnological interventions for treatment of trypanosomiasis in humans and animals. Drug Deliv Transl 10:945–961
Robert-Gangneux F, Dardé ML et al (2012) Epidemiology of and diagnostic strategies for toxoplasmosis. JCM 25(2):264–296
Royal A et al (2023) A cost-effectiveness analysis of pre-exposure prophylaxis to avert rabies deaths in school-aged children in India. Vaccine 11(3):677
Seidel JS, Harmatz P, Visvesvara GS, Cohen A, Edwards J, Turner J (1982) Successful treatment of primary amebic meningoencephalitis. N Engl J Med 306(6):346–348
Sibanda T, Buys EM (2022) Listeria monocytogenes pathogenesis: the role of stress adaptation. Microorganisms 10(8):1522
Sinah S, Sehgal R (2022) Nano-targeted drug delivery for parasitic infections. In: Emerging nanomaterials and nano-based drug delivery approaches to combat antimicrobial resistance. Elsevier, pp 395–424
Singh CK, Ahmad A (2018) Molecular approach for antemortem diagnosis of rabies in dogs. IJMR 147(5):513
Singh AV, Patil R, Thombre DK, Gade WN (2013) Micro-nanopatterning as tool to study the role of physicochemical properties on cell–surface interactions. J Biomed Mat Res A 101(10):3019–3032
Skariah S, McIntyre MK, Mordue DG et al (2012) Toxoplasma gondii: determinants of tachyzoite to bradyzoite conversion. Parasitol Res 107:253–260
Slingenbergh J (2013) World Livestock 2013: changing disease landscapes. Food and Agriculture Organization of the United Nations (FAO)
Taha BA et al (2023) Next-generation nanophotonic-enabled biosensors for intelligent diagnosis of SARS-CoV-2 variants. Sci Total Environ 880:163333
Taylor LH, Latham SM, Woolhouse ME (2001) Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci 356(1411):983–989
Tee BL, Ibarrola EML, Geschwind MD (2018) Prion diseases. Neurol Clin 36(4):865–897
Thompson A, Kutz S (2019) Introduction to the special issue on ‘Emerging zoonoses and wildlife’. Int J Parasitol Parasites Wildl 9:322
Varshney M, Waggoner PS, Tan CP, Aubin K, Montagna RA, Craighead HG (2008) Prion protein detection using nanomechanical resonator arrays and secondary mass labeling. Anal Chem 80(6):2141–2148
Vashist A, Manickam P, Raymond AD, Arias AY, Kolishetti N, Vashist A, Arias E, Nair M (2023) Recent advances in nanotherapeutics for neurological disorders. ACS Appl Bio Mater 6(7):2614–2621
Vauthier C, Couvreur P (2007) Nanomedicines: a new approach for the treatment of serious diseases. J Biomed Nanotechnol 3(3):223–234
Walvekar P, Gannimani R, Govender T (2019) Combination drug therapy via nanocarriers against infectious diseases. Eur J Pharm Sci 127:121–141
Wang P, Hatcher KL, Bartz JC, Chen SG, Skinner P, Richt J, Liu H, Sreevatsan S (2011) Selection and characterization of DNA aptamers against PrPSc. Exp Biol Med 236(4):466–476
Yamashita F, Hashida M (2013) Pharmacokinetic considerations for targeted drug delivery. Adv Drug Deliv Rev 65(1):139–147
Yang Y, Xu F, Xu H, Aguilar ZP, Niu R, Yuan Y, Sun J, You X, Lai W, Xiong Y, Wan C et al (2013) Magnetic nano-beads based separation combined with propidium monoazide treatment and multiplex PCR assay for simultaneous detection of viable Salmonella Typhimurium, Escherichia coli O157:H7 and Listeria monocytogenes in food products. Food Microbiol 34(2):418–424
Zahir-Jouzdani F, Mottaghitalab F, Dinarvand M, Atyabi F (2018) siRNA delivery for treatment of degenerative diseases, new hopes and challenges. J Drug Deliv Sci Technol 45:428–441
Zhang Y, Qi S, Liu Z, Shi Y, Yue W, Yi C (2016) Rapid determination of dopamine in human plasma using a gold nanoparticle-based dual-mode sensing system. Mater Sci Eng C 61:207–213
Zhang RX, Li J, Zhang T, Amini MA, He C, Lu B, Ahmed T, Lip H, Rauth AM, Wu XY (2018) Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy—an illustration with firsthand examples. Acta Pharmacol Sin 39(5):825–844
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Wazir, N. et al. (2023). Role of Nanoparticles and Nanotherapeutics in the Diagnosis of Serious Zoonotic and Neurological Diseases. In: Gautam, A., Chaudhary, V. (eds) Theranostic Applications of Nanotechnology in Neurological Disorders. Springer, Singapore. https://doi.org/10.1007/978-981-99-9510-3_6
Download citation
DOI: https://doi.org/10.1007/978-981-99-9510-3_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-9509-7
Online ISBN: 978-981-99-9510-3
eBook Packages: MedicineMedicine (R0)